An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Completed · Phase 1

Conditions studied: Non-Hodgkin's Lymphoma

In brief

This is a Phase 1, open-label, multicenter, extension study. Subjects with non-Hodgkin's lymphoma (NHL) (excluding chronic lymphocytic lymphoma \[CLL\], small lymphocytic lymphoma \[SLL\], and mantle cell lymphoma \[MCL\]) who completed a prior ABT-199 study, or were active and assigned to ABT-199 when the study was completed, may roll over into this extension study. Subjects will receive ABT-199 during this study.

Key facts

Study ID
NCT01969695
Run by
AbbVie
People needed
11
Starts
2013-12-20
Expected to finish
2019-12-16
Last updated by the study team
2019-12-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.